世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

3Dプリント医薬品市場 - 世界の産業規模、シェア、動向、機会、予測、2017-2027年 技術別(インクジェット印刷、Fused Deposition Modeling、Stereolithography、ZipDose Technology、その他)、用途別(整形外科、神経、歯科、その他)、エンドユーザー別(病院・クリニック、学術・研究機関、その他)、地域別で区分。


3D Printed Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2017-2027 Segmented by Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others), By Application (Orthopedic, Neurology, Dental, Others), By End User (Hospitals & Clincs, Academic & Research Institutions, Others), By Region

世界の3Dプリント医薬品市場は、予測期間中に目覚ましい成長を目撃すると予想されます。これは、3Dプリント薬の使用に関連する利点について、人々や患者の間で意識が高まっていることに起因している可能性があり... もっと見る

 

 

出版社 出版年月 電子版価格 ページ数 言語
TechSci Research
テックサイリサーチ
2022年12月1日 US$4,900
シングルユーザライセンス(印刷不可)
ライセンス・価格情報
注文方法はこちら
119 英語

 

サマリー

世界の3Dプリント医薬品市場は、予測期間中に目覚ましい成長を目撃すると予想されます。これは、3Dプリント薬の使用に関連する利点について、人々や患者の間で意識が高まっていることに起因している可能性があります。さらに、嚥下障害を患う患者の増加も、今後数年間の市場成長をサポートすると予想されます。嚥下障害は、嚥下困難によって特徴付けられます。この病気では、食べ物や液体を口から胃に移すのに多くの時間と労力を要します。3Dプリント医薬品は、3Dプリント技術によって作成された医薬品で、嚥下障害に苦しむ患者の治療に使用されます。3Dプリント医薬品は、多孔質構造を持ち、口腔内で急速に崩壊することができます。また、さまざまな病気に関連する新薬を発明するための政府組織による投資の増加や、人々や医療従事者の間で3Dプリント薬の使用に関する意識が高まっていることも、予測期間中の市場成長をさらに後押しすることになります。さらに、個別化医療の人気の高まりは、市場成長のための有利な機会を生み出すと予想されます。
慢性疾患の有病率の増加
世界中で糖尿病、癌、心血管疾患、腎臓問題などの慢性疾患の有病率が高まっていることから、世界の3Dプリント医薬品市場の成長に有利な機会を創出すると期待されています。グローバル癌観測所によると、2020年には世界で約19,292,789件の新規癌症例が報告され、乳癌、肺癌、大腸癌、前立腺癌、胃癌が最も多く見られるタイプであることが分かっている。このため、さまざまな種類のがんの治療用として3Dプリンターによる薬剤の需要が高まると予想されます。さらに、さまざまな病気にかかりやすい老人の人口が世界中で増加しているため、効果的なだけでなく手頃な価格の薬が必要とされており、それによって世界の3Dプリント医薬品市場の成長を加速している。

3Dプリント医薬品に関連する利点
3Dプリント医薬品の使用には、この技術を使用して、慎重に調整された形状、投与量、サイズなどの医薬品を小ロットで製造できるなど、数多くの利点があります。さらに、3Dプリント技術を使用することで、製造コストを大幅に削減することができます。このため、この分野への投資が増加し、予測期間中の市場成長を支えるものと期待されています。しかし、即時溶解性、製造時間の短縮、廃棄物の削減、容易なオンデマンド製造など、これらの医薬品の利点に対する認知度の向上は、市場成長のための複数の展望を生み出すと思われます。

市場細分化
世界の3Dプリント医薬品市場は、技術別、用途別、エンドユーザー別、地域別に区分することができます。技術に基づいて、市場はインクジェット印刷、溶融堆積モデリング、ステレオリソグラフィ、Zipdose技術、その他に分類することができます。アプリケーションに基づくと、市場は整形外科、神経科、歯科、その他に細分化することができます。エンドユーザー別に見ると、病院・クリニック、学術・研究機関、その他に分類されます。地域別では、ヨーロッパ、アジア太平洋地域、中東・アフリカ、南米の中で、北米が市場を独占しています。さまざまな国の中で、米国が世界の3Dプリント医薬品市場を独占しました。これは、米国で個別化医薬品の採用、使用、入手が拡大しているためです。2020年に米国で利用可能なパーソナライズド医薬品の数は、約286。

市場参入企業
Aprecia Pharmaceuticals, LLC.、FabRx Ltd.、Merck & Co.Inc.、Triastek, Inc.、GlaxoSmithKline plc、Formac Pharmaceuticals N.V.、AstraZeneca plc、Extend Biosciences, Inc、Affinity Therapeutics, LLC、Osmotica Pharmaceuticals Corporationなどは、世界の3Dプリント医薬品市場で活動する大手企業の一例である。

レポートの範囲
本レポートでは、3Dプリント薬の世界市場を、以下に詳述する業界動向に加えて、以下のカテゴリーに分類しています。
- 3Dプリント薬剤の世界市場:技術別
o インクジェットプリンティング
o Fused Deposition Modeling(溶融堆積モデリング
o ステレオリソグラフィー
o ジップドーズ技術
o その他
- 3Dプリント医薬品市場、用途別
o 整形外科
o 神経
o 歯科
o その他
- 3Dプリント医薬品市場:エンドユーザー別
o 病院と診療所
o 学術・研究機関
o その他
- 3Dプリント医薬品市場:地域別
o 北米
米国
カナダ
メキシコ
o ヨーロッパ
フランス
ドイツ
イギリス
イタリア
スペイン
o アジア太平洋地域
中国
インド
日本
韓国
オーストラリア
o 南米
ブラジル
アルゼンチン
コロンビア
o 中東・アフリカ
南アフリカ共和国
サウジアラビア
UAE
トルコ
エジプト
競合他社の状況
企業プロファイル。3Dプリント医薬品の世界市場における主要企業の詳細分析
利用可能なカスタマイズ。
TechSci Researchでは、与えられた市場データをもとに、企業の特定のニーズに応じたカスタマイズを提供しています。このレポートでは、以下のカスタマイズが可能です。
企業情報
- 追加的な市場プレイヤーの詳細分析とプロファイリング(最大5社)。

ページTOPに戻る


目次

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global 3D Printed Drugs Market
5. Voice of Customer
6. Global 3D Printed Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others)
6.2.2. By Application (Orthopedic, Neurology, Dental, Others)
6.2.3. By End User (Hospitals & Clincs, Academic & Research Institutions, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America 3D Printed Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States 3D Printed Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada 3D Printed Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico 3D Printed Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe 3D Printed Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France 3D Printed Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Germany 3D Printed Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. United Kingdom 3D Printed Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy 3D Printed Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain 3D Printed Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific 3D Printed Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China 3D Printed Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India 3D Printed Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan 3D Printed Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea 3D Printed Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technology
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia 3D Printed Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Technology
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America 3D Printed Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil 3D Printed Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina 3D Printed Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia 3D Printed Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa 3D Printed Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Application
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa 3D Printed Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Technology
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia 3D Printed Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Technology
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE 3D Printed Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Technology
11.3.3.2.2. By Application
11.3.3.2.3. By End User
11.3.4. Turkey 3D Printed Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Technology
11.3.4.2.2. By Application
11.3.4.2.3. By End User
11.3.5. Egypt 3D Printed Drugs Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Technology
11.3.5.2.2. By Application
11.3.5.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Aprecia Pharmaceuticals, LLC.
14.2. FabRx Ltd.
14.3. Merck & Co. Inc.
14.4. Triastek, Inc.
14.5. GlaxoSmithKline plc.
14.6. Formac Pharmaceuticals N.V.
14.7. AstraZeneca plc
14.8. Extend Biosciences, Inc.
14.9. Affinity Therapeutics, LLC
14.10. Osmotica Pharmaceuticals Corporation
15. Strategic Recommendations

 

ページTOPに戻る


 

Summary

The global 3d printed drugs market is anticipated to witness an impressive growth during the forecast period. This can be ascribed to increasing awareness amongst people and patients regarding the benefits associated with the usage of 3D printed drugs. Besides increasing number of patients suffering from dysphagia is expected to support the market growth in the coming years. Dysphagia is characterized by difficulty in swallowing. In this disease, it takes more time and effort to move food or liquid from mouth to stomach. 3D printed drugs are drugs created by 3D printing technology that are used to treat patients suffering from dysphagia. 3D printed drugs have a porous structure that can rapidly disintegrate in the mouth. Besides, increasing investments by government organizations for inventing new drugs related to different diseases couples with growing awareness regarding usage of 3D printed drugs among people and healthcare providers will further boost the market growth in the forecast period. Furthermore, growing popularity of personalized medicine is further expected to create lucrative opportunities for the market growth.
Increasing Prevalence of Chronic Diseases
The growing prevalence of chronic diseases such as diabetes, cancer, cardiovascular diseases, renal problems, among others across the globe is expected to create lucrative opportunities for the growth of global 3D printed drugs market. According to global cancer observatory, around 19,292,789 new cancer cases were reported worldwide in 2020, with breast cancer, lung cancer, colorectum cancer, prostate cancer and stomach cancer being the most prevalent types. This in turn is expected to increase the demand for 3D printed drugs for the treatment of different types of cancers. Additionally, growing geriatric population across the globe which is susceptible to various diseases requires medications that are not only effective but also affordable, thereby fuelling the growth of global 3D printed drugs market.

Benefits Associated With 3D Printed Drugs
There are numerous benefits associated with the use of 3D Printed Drugs such as using this technique medicines can be produced in small batches with carefully tailored shapes, dosages, and sizes, among others. In addition, the use of 3D printing technology can significantly reduce manufacturing costs. This in turn is expected to increase investments in this space, thereby supporting the market growth during the forecast period. However, increased awareness of the benefits of these medications, such as their immediate solubility, faster manufacturing time, reduced waste, and easy on-demand manufacturing is likely to create multiple prospects for market growth.

Market Segmentation
The Global 3D Printed Drugs market can be segmented by technology, by application, by end user, and by region. Based on technology, the market can be categorized into inkjet printing, fused deposition modeling, stereolithography, zipdose technology, and others. Based on application, the market can be fragmented into orthopedic, neurology, dental, and others. Based on end user, the market can be grouped into hospitals & clincs, academic & research institutions, and others. Regionally, North America dominated the market among Europe, Asia Pacific, Middle East & Africa, and South America. Among the different countries, United States dominated the Global 3D Printed Drugs Market on account of growing adoption, use and availability of personalized medicines in the United States. The number of personalized medicines available in the United States in 2020 were around 286.

Market Players
Aprecia Pharmaceuticals, LLC., FabRx Ltd., Merck & Co. Inc., Triastek, Inc., GlaxoSmithKline plc., Formac Pharmaceuticals N.V., AstraZeneca plc, Extend Biosciences, Inc., Affinity Therapeutics, LLC, Osmotica Pharmaceuticals Corporation are some of the leading players operating in the Global 3D Printed Drugs Market.

Report Scope:
In this report, Global 3D Printed Drugs Market has been segmented into following categories, in addition to the industry trends which have also been detailed below:
• 3D Printed Drugs Market, By Technology:
o Inkjet Printing
o Fused Deposition Modeling
o Stereolithography
o Zip Dose Technology
o Others
• 3D Printed Drugs Market, By Application:
o Orthopedic
o Neurology
o Dental
o Others
• 3D Printed Drugs Market, By End User:
o Hospital & Clinics
o Academic & Research Institutions
o Others
• 3D Printed Drugs Market, By Region:
o North America
 United States
 Canada
 Mexico
o Europe
 France
 Germany
 United Kingdom
 Italy
 Spain
o Asia Pacific
 China
 India
 Japan
 South Korea
 Australia
o South America
 Brazil
 Argentina
 Colombia
o Middle East & Africa
 South Africa
 Saudi Arabia
 UAE
 Turkey
 Egypt
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in Global 3D Printed Drugs Market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company’s specific needs. The following customization options are available for the report:
Company Information
• Detailed analysis and profiling of additional market players (up to five).



ページTOPに戻る


Table of Contents

1. Product Overview
2. Research Methodology
3. Executive Summary
4. Impact of COVID-19 on Global 3D Printed Drugs Market
5. Voice of Customer
6. Global 3D Printed Drugs Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Technology (Inkjet Printing, Fused Deposition Modeling, Stereolithography, ZipDose Technology, Others)
6.2.2. By Application (Orthopedic, Neurology, Dental, Others)
6.2.3. By End User (Hospitals & Clincs, Academic & Research Institutions, Others)
6.2.4. By Company (2021)
6.2.5. By Region
6.3. Market Map
7. North America 3D Printed Drugs Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Technology
7.2.2. By Application
7.2.3. By End User
7.2.4. By Country
7.3. North America: Country Analysis
7.3.1. United States 3D Printed Drugs Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Technology
7.3.1.2.2. By Application
7.3.1.2.3. By End User
7.3.2. Canada 3D Printed Drugs Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Technology
7.3.2.2.2. By Application
7.3.2.2.3. By End User
7.3.3. Mexico 3D Printed Drugs Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Technology
7.3.3.2.2. By Application
7.3.3.2.3. By End User
8. Europe 3D Printed Drugs Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Technology
8.2.2. By Application
8.2.3. By End User
8.2.4. By Country
8.3. Europe: Country Analysis
8.3.1. France 3D Printed Drugs Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Technology
8.3.1.2.2. By Application
8.3.1.2.3. By End User
8.3.2. Germany 3D Printed Drugs Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Technology
8.3.2.2.2. By Application
8.3.2.2.3. By End User
8.3.3. United Kingdom 3D Printed Drugs Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Technology
8.3.3.2.2. By Application
8.3.3.2.3. By End User
8.3.4. Italy 3D Printed Drugs Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Technology
8.3.4.2.2. By Application
8.3.4.2.3. By End User
8.3.5. Spain 3D Printed Drugs Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Technology
8.3.5.2.2. By Application
8.3.5.2.3. By End User
9. Asia-Pacific 3D Printed Drugs Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Technology
9.2.2. By Application
9.2.3. By End User
9.2.4. By Country
9.3. Asia-Pacific: Country Analysis
9.3.1. China 3D Printed Drugs Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Technology
9.3.1.2.2. By Application
9.3.1.2.3. By End User
9.3.2. India 3D Printed Drugs Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Technology
9.3.2.2.2. By Application
9.3.2.2.3. By End User
9.3.3. Japan 3D Printed Drugs Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Technology
9.3.3.2.2. By Application
9.3.3.2.3. By End User
9.3.4. South Korea 3D Printed Drugs Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Technology
9.3.4.2.2. By Application
9.3.4.2.3. By End User
9.3.5. Australia 3D Printed Drugs Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Technology
9.3.5.2.2. By Application
9.3.5.2.3. By End User
10. South America 3D Printed Drugs Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Technology
10.2.2. By Application
10.2.3. By End User
10.2.4. By Country
10.3. South America: Country Analysis
10.3.1. Brazil 3D Printed Drugs Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Technology
10.3.1.2.2. By Application
10.3.1.2.3. By End User
10.3.2. Argentina 3D Printed Drugs Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Technology
10.3.2.2.2. By Application
10.3.2.2.3. By End User
10.3.3. Colombia 3D Printed Drugs Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Technology
10.3.3.2.2. By Application
10.3.3.2.3. By End User
11. Middle East and Africa 3D Printed Drugs Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Technology
11.2.2. By Application
11.2.3. By End User
11.2.4. By Country
11.3. MEA: Country Analysis
11.3.1. South Africa 3D Printed Drugs Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Technology
11.3.1.2.2. By Application
11.3.1.2.3. By End User
11.3.2. Saudi Arabia 3D Printed Drugs Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Technology
11.3.2.2.2. By Application
11.3.2.2.3. By End User
11.3.3. UAE 3D Printed Drugs Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Technology
11.3.3.2.2. By Application
11.3.3.2.3. By End User
11.3.4. Turkey 3D Printed Drugs Market Outlook
11.3.4.1. Market Size & Forecast
11.3.4.1.1. By Value
11.3.4.2. Market Share & Forecast
11.3.4.2.1. By Technology
11.3.4.2.2. By Application
11.3.4.2.3. By End User
11.3.5. Egypt 3D Printed Drugs Market Outlook
11.3.5.1. Market Size & Forecast
11.3.5.1.1. By Value
11.3.5.2. Market Share & Forecast
11.3.5.2.1. By Technology
11.3.5.2.2. By Application
11.3.5.2.3. By End User
12. Market Dynamics
12.1. Drivers
12.2. Challenges
13. Market Trends & Developments
14. Competitive Landscape
14.1. Aprecia Pharmaceuticals, LLC.
14.2. FabRx Ltd.
14.3. Merck & Co. Inc.
14.4. Triastek, Inc.
14.5. GlaxoSmithKline plc.
14.6. Formac Pharmaceuticals N.V.
14.7. AstraZeneca plc
14.8. Extend Biosciences, Inc.
14.9. Affinity Therapeutics, LLC
14.10. Osmotica Pharmaceuticals Corporation
15. Strategic Recommendations

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

TechSci Research社のその他分野での最新刊レポート


よくあるご質問


TechSci Research社はどのような調査会社ですか?


テックサイリサーチ(TechSci Research)は、カナダ、英国、インドに拠点を持ち、化学、IT、環境、消費財と小売、自動車、エネルギーと発電の市場など、多様な産業や地域を対象とした調査・出版活... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/12/20 10:28

158.95 円

165.20 円

201.28 円

ページTOPに戻る